In this study, corresponding to the high metastatic frequency of CRC in patients with low APC2 expression, we also found that the 5-year survival rate of these patients was significantly lower than that of patients with high APC2 expression, suggesting that low APC2 expression predicted poor prognosis of CRC. Here, APC2 is linked to colorectal carcinoma.